Abnormalities of mitochondrial enzymes in Alzheimer disease

Gibson, G. E., Sheu, K.-F. R., Blass, J. P.·1998·Journal of Neural Transmission
DOI 10.1007/s007020050099

Cited by (345)

Items 201–300 of 345

  1. Changes in mitochondrial bioenergetics in the brain versus spinal cord become more apparent with age
    Heather M. Yonutas, Jignesh D. Pandya, Patrick G. Sullivan · 2014 · Journal of Bioenergetics and Biomembranes
  2. Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system
    Mohammad Umar, Yasir Rehman, Subiya Ambreen, Sayed Md Mumtaz, Mohd Shaququzzaman, Mohammad Mumtaz Alam, Ruhi Ali · 2024 · Ageing Research Reviews
  3. Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
    Tiziana Casoli, Liana Spazzafumo, Giuseppina Di Stefano, Fiorenzo Conti · 2015 · Frontiers in Aging Neuroscience
  4. Expression of a Truncated Human Tau Protein Induces Aqueous-Phase Free Radicals in a Rat Model of Tauopathy: Implications for Targeted Antioxidative Therapy
    Martin Cente, Peter Filipčík, Stanislava Mandakova, Norbert Žilka, Gabriela Krajciova, Michal Novák · 2009 · Journal of Alzheimer s Disease
  5. Amyloid-β–Induced Changes in Molecular Clock Properties and Cellular Bioenergetics
    Karen Schmitt, Amandine Grimm, Anne Eckert · 2017 · Frontiers in Neuroscience
  6. Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease
    Beata Pająk, Elżbieta Kania, Arkadiusz Orzechowski · 2016 · Oxidative Medicine and Cellular Longevity
  7. Unravelling protein aggregation as an ageing related process or a neuropathological response
    Diogo Trigo, André Nadais, Odete A. B. da Cruz e Silva · 2019 · Ageing Research Reviews
  8. Thiamine and Oxidants Interact to Modify Cellular Calcium Stores
    Hsueh‐Meei Huang, Huan‐Lian Chen, Gary E. Gibson · 2010 · Neurochemical Research
  9. Quantitative α-Ketoglutarate Dehydrogenase Activity Staining in Brain Sections and in Cultured Cells
    Larry C.H. Park, Noel Ylagan Calingasan, Kwan‐Fu Rex Sheu, Gary E. Gibson · 2000 · Analytical Biochemistry
  10. Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer’s Disease Brain
    Taher Darreh‐Shori, Sareh Rezaeianyazdi, Erica Lana, Sumonto Mitra, Anna Gellerbring, Azadeh Karami, Nenad Bogdanović, Christina Unger Lithner, Bengt G. Winblad, Homira Behbahani · 2018 · Molecular Neurobiology
  11. Alterations of some membranetransportproteins in Alzheimer's disease: role of amyloid β-peptide
    Rukhsana Sultana A, David Allan Butterfield · 2007 · Molecular BioSystems
  12. Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease
    Feldhaus, Pollyana, Fraga, Daiane B., Ghedim, Fernando V., De Luca, Renata D., Bruna, Thiago D., Heluany, Matheus, Matos, Maria Paula, Ferreira, Gabriela K., Jeremias, Isabela C., Heluany, Claudia et al. · 2011 · Metabolic Brain Disease
  13. Protective effect of curcuminoids on age-related mitochondrial impairment in female Wistar rat brain
    Manisha Rastogi, Rudra Prakash Ojha, Chandrasekhar Sagar, Aruna Agrawal, Govind Prasad Dubey · 2013 · Biogerontology
  14. Methylene blue improves streptozotocin-induced memory deficit by restoring mitochondrial function in rats
    Lei Li, Qin Li, Hai-long Lu, Pingjing Li, Yuanjian Song, Rong-Li Yang · 2016 · Brain Research
  15. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases
    Aleksandra Maruszak, Katarzyna Gawęda-Walerych, Ireneusz Sołtyszewski, And Zekanowski · 2006 · Acta Neurobiologiae Experimentalis
  16. Vulnerability of neurons with mitochondrial dysfunction to oxidative stress is associated with down-regulation of thioredoxin
    Jing Gao, Zeng‐Rong Zhu, Hongqun Ding, Zhong‐Ming Qian, Li Zhu, Ya Ke · 2006 · Neurochemistry International
  17. Pathogenic role of mitochondrial amyloid-β peptide
    John Xi Chen, Shi Du Yan · 2007 · Expert Review of Neurotherapeutics
  18. Existing Data Suggest That Alzheimer's Disease Is Preventable
    Mark P. Mattson · 2000 · Annals of the New York Academy of Sciences
  19. Interaction of a novel mitochondrial protein, 4‐nitrophenylphosphatase domain and non‐neuronal SNAP25‐like protein homolog 1 (NIPSNAP1), with the amyloid precursor protein family
    Hemachand Tummala, Xiaofan Li, Ramin Homayouni · 2010 · European Journal of Neuroscience
  20. A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
    Kurt Heininger · 1999 · Human Psychopharmacology Clinical and Experimental
  21. (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia
    Lutz Fr�lich, M. E. G�tz, M. Weinm�ller, Moussa B. H. Youdim, N. Barth, Albrecht Dirr, Wieland Gsell, Kurt A. Jellinger, H. Beckmann, Peter Franz Riederer · 2004 · Journal of Neural Transmission
  22. Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer’s disease
    Flávio Moreira de Morais, Angela Maria Ribeiro, Fabrício A. Moreira, Pollyanna V. G. Silva · 2020 · Acta Neuropsychiatrica
  23. Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer’s disease and decreases it in wild-type mice
    Elena Galea, Douglas L. Feinstein, Pierre M. Lacombe · 2006 · Diabetologia
  24. Therapeutic strategies in Friedreich's Ataxia
    Timothy E. Richardson, Heather N. Kelly, Amanda E. Yu, James W. Simpkins · 2013 · Brain Research
  25. Neuroimmunomodulatory steroids in Alzheimer dementia
    Richard Hampl, Marie Bičı́ková · 2010 · The Journal of Steroid Biochemistry and Molecular Biology
  26. Reporter pathway analysis from transcriptome data: Metabolite-centric versus Reaction-centric approach
    Tunahan Çakır · 2015 · Scientific Reports
  27. Effects of estrogens and androgens on mitochondria under normal and pathological conditions
    Mohammad Mohajeri, Cynthia Martín-Jiménez, George Emilio Barreto, Amirhossein Sahebkar · 2019 · Progress in Neurobiology
  28. Alterations in mitochondrial number and function in Alzheimer’s disease fibroblasts
    Nora E. Gray, Joseph F. Quinn · 2015 · Metabolic Brain Disease
  29. Anaplerosis for Glutamate Synthesis in the Neonate and in Adulthood
    Eva Brekke, Tora Sund Morken, Anne B. Walls, Helle S. Waagepetersen, Arne Schousboe, Ursula Sonnewald · 2016 · Advances in neurobiology
  30. Synergistic effects of β-amyloid and ceramide-induced insulin resistance on mitochondrial metabolism in neuronal cells
    Bumsup Kwon, Timothy Gamache, Hankyu Lee, Henry W. Querfurth · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Testing for Linkage and Association Across the Dihydrolipoyl Dehydrogenase Gene Region with Alzheimer’s Disease in Three Sample Populations
    Abraham M. Brown, Derek Gordon, Hsinhwa Lee, Fabienne Wavrant‐De Vrièze, Elena Cellini, Silvia Bagnoli, Benedetta Nacmias, Sandro Sorbi, John Hardy, John P. Blass · 2007 · Neurochemical Research
  32. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
  33. Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer’s Disease: Analysis of 13 Cases
    Yucai Chen, Changsheng Liu, William Davis Parker, Hongyi Chen, Thomas G. Beach, Xinhua Liu, Geidy E. Serrano, Yanfen Lu, Jianjun Huang, Kunfang Yang et al. · 2016 · PLoS ONE
  34. Inhibition of heme synthesis alters Amyloid Precursor Protein processing
    Luisa Benerini Gatta, Massimiliano Andrea Vitali, Rosanna Verardi, Paolo Arosio, Dario Finazzi · 2008 · Journal of Neural Transmission
  35. Stabilization of ubiquitous mitochondrial creatine kinase preprotein by APP family proteins
    Xiaofan Li, Tanja S. Bürklen, Xianglin Yuan, Uwe Schlattner, Dominic M. Desiderio, Theo Wallimann, Ramin Homayouni · 2005 · Molecular and Cellular Neuroscience
  36. SuperAgers and centenarians, dynamics of healthy ageing with cognitive resilience
    Md. Ariful Islam, Ujala Sehar, Omme Fatema Sultana, Upasana Mukherjee, Malcolm Brownell, Sudhir Kshirsagar, P. Hemachandra Reddy · 2024 · Mechanisms of Ageing and Development
  37. Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population
    Abraham M. Brown, Derek Gordon, Hsinhwa Lee, Michael A. Caudy, John Hardy, Vahram H. Haroutunian, John P. Blass · 2004 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  38. DOOR syndrome: Deficiency of E1 component of the 2‐oxoglutarate dehydrogenase complex
    Sankar Surendran, Kimberlee Michals‐Matalon, Steve Krywawych, Qutub H. Qazi, Roberto F. Tuchman, Peter L. Rady, Stephan K. Tyring, Reuben K. Matalon · 2002 · American Journal of Medical Genetics
  39. Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation
    Katalin Völgyi, Krisztina Háden, Viktor Kis, Péter Gulyássy, Kata Badics, Balázs A. Györffy, Attila Simor, Zoltán Szabó, Tamás Janáky, László Drahos et al. · 2016 · Molecular Neurobiology
  40. The Rationale for Insulin Therapy in Alzheimer’s Disease
    Samo Ribarič · 2016 · Molecules
  41. Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
    Richa Aishwarya, Chowdhury S. Abdullah, Naznin Sultana Remex, Mohammad Alfrad Nobel Bhuiyan, Xiao‐Hong Lu, Nirav Dhanesha, Karen Yvonne Stokes, Anthony Wayne Orr, Christopher G. Kevil, Md. Shenuarin Bhuiyan · 2024 · Scientific Reports
  42. Disruption of Calcium Homeostasis in Alzheimer’s Disease
    T. Yu. Korol’, Sergiy V. Korol, Elena P. Kostyuk, Platon G. Kostyuk · 2008 · Neurophysiology
  43. Mitochondrial amyloid-beta peptide: Pathogenesis or late-phase development?
    Shi Du Yan, Wen‐Cheng Xiong, David M. Stern · 2006 · Journal of Alzheimer s Disease
  44. Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer’s disease cybrid cells☆
    Patrizia De Sarno, Gautam N. Bijur, Rong Lü, Robert E. Davis, Richard Scott Jope · 2000 · Neurobiology of Aging
  45. Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer’s Disease with Therapeutic Implications
    Hyein Song, Jiyong Lee, Yeeun Lee, Seungju Kim, Shinwoo Kang · 2025 · International Journal of Molecular Sciences
  46. Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
    Carolin Thomas, Lia Wurzer, Ernst Malle, Michael Ristow, Corina T. Madreiter‐Sokolowski · 2022 · Frontiers in Aging
  47. Mitochondrial Drugs for Alzheimer Disease
    David Bonda, Xinglong Wang, Katarzyna Gustaw‐Rothenberg, George L. Perry, Mark A. Smith, Xiongwei Zhu · 2009 · Pharmaceuticals
  48. Roles of dihydrolipoamide dehydrogenase Lpd1 in Candida albicans filamentation
    Seung-Yeop Kim, Jinmi Kim · 2010 · Fungal Genetics and Biology
  49. Cross-species metabolomic analysis of tau- and DDT-related toxicity
    Vrinda Kalia, Megan M. Niedzwiecki, Joshua M. Bradner, Fion K. Lau, Faith L. Anderson, Meghan L. Bucher, Katherine E. Manz, Alexa P. Schlotter, Zoe Coates Fuentes, Kurt D. Pennell et al. · 2022 · PNAS Nexus
  50. Road to Alzheimer’s Disease: The Pathomechanism Underlying
    Ruban Anand, Alka Kaushal, Willayat Yousuf Wani, Kiran Dip Gill · 2011 · Pathobiology
  51. Recommendations for the analysis of gene expression data to identify intrinsic differences between similar tissues
    Tooba Abbassi‐Daloii, Hermien E. Kan, Vered Raz, Peter A.C. ’t Hoen · 2020 · Genomics
  52. Gene expression profile in β-amyloid-treated SH-SY5Y neuroblastoma cells
    Tamara Martínez, Angel Pascual · 2007 · Brain Research Bulletin
  53. RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT
    Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur · 2016 · International Journal of Pharmacy and Pharmaceutical Sciences
  54. Is the Brain Undernourished in Alzheimer’s Disease?
    Roberto Aquilani, Alfredo Cardoso Costa, Roberto Maestri, Matteo Cotta Ramusino, Giulia Perini, Mirella Boselli, Paolo Iadarola, Daniela Buonocore, Manuela Verri, Maurizia Dossena et al. · 2022 · Nutrients
  55. Estrés oxidativo y enfermedad de Alzheimer
    Félix Javier Jiménez Jiménez, Hortensia Alonso Navarro, Lucía Ayuso‐Peralta, Theresse Jabbour Wadih · 2006 · Revista de Neurología
  56. Altered phosphofructokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease
    Marina Bigl, M Beck, Anna‐Dorothea Bleyl, Volker Bigl, Klaus Eschrich · 2000 · Molecular Brain Research
  57. Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
    Jonathan J. Kopel, Ujala Sehar, Moumita Choudhury, P. Hemachandra Reddy · 2023 · Healthcare
  58. Fluorescence microscopic platforms imaging mitochondrial abnormalities in neurodegenerative diseases
    Yicheng Wang, Pengwei Wang, Cong Li · 2023 · Advanced Drug Delivery Reviews
  59. Artificial Intelligence Predictor for Alzheimer’s Disease Trained on Blood Transcriptome: The Role of Oxidative Stress
    Luigi Chiricosta, Simone D’Angiolini, Agnese Gugliandolo, Emanuela Mazzon · 2022 · International Journal of Molecular Sciences
  60. Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease
    Marcel Victor Alavi · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  61. Mitochondrial Dynamics in Neurodegenerative Diseases
    Jennifer R. Pinnell, Kim Tieu · 2017 · Advances in neurotoxicology
  62. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
    Md. Mominur Rahman, Mst. Afroza Alam Tumpa, Md. Saidur Rahaman, Fahadul Islam, Popy Rani Sutradhar, Muniruddin Ahmed, Badrah Saeed Ali Alghamdi, Abdul Hafeez, Athanasios T. Alexiou, Asma Perveen et al. · 2023 · Current Neuropharmacology
  63. Tongluo Xingnao Effervescent Tablet preserves mitochondrial energy metabolism and attenuates cognition deficits in APPswe/PS1De9 mice
    Yuan Dai, Tao Ma, Ren Xiangyi, Jiangping Wei, Wenjun Fu, Yuntong Ma, Shijun Xu, Zhanjun Zhang · 2016 · Neuroscience Letters
  64. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer’s Disease
    Johannes Steffen, Jan Stenzel, Saleh Mohamed Ibrahim, Jens Pahnke · 2018 · Journal of Alzheimer s Disease
  65. In vitro effects of acetylcholinesterase inhibitors and reactivators on Complex I of electron transport chain.
    Jana Hroudová, Zdeněk Fišar, Jan Korábečný, Kamil Kuča · 2011 · PubMed
  66. Dimebon as a Potential Therapy for Alzheimer's Disease
    Rachelle Smith Doody · 2009 · CNS Spectrums
  67. Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools
    Vanlalrinchhani Varte, Jeremy W Munkelwitz, Diego E. Rincón-Limas · 2023 · Frontiers in Neuroscience
  68. Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives
    Jana Hroudová, Zdeněk Fišar · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  69. The T9861C Mutation in the mtDNA-Encoded Cytochrome C Oxidase Subunit III Gene Occurs in High Frequency but with Unequal Distribution in the Alzheimer’s Disease Brain
    Frank J. Castora, Barbara Conyers, Blake S Gershon, Kimberly A. Kerns, Robert Campbell,, Fatma Simsek‐Duran · 2019 · Journal of Alzheimer s Disease
  70. Cortical Metabolic Deficits in a Rat Model of Cholinergic Basal Forebrain Degeneration
    Francesca Gelfo, Laura Petrosini, Alessandro Graziano, Paola De Bartolo, Lorena Burello, Emilia Vitale, Arianna Polverino, Antonietta Iuliano, Giuseppe Sorrentino, Laura Mandolesi · 2013 · Neurochemical Research
  71. Protective Effect of α‐Keto‐β‐Methyl‐n‐Valeric Acid on BV‐2 Microglia under Hypoxia or Oxidative Stress
    Hsueh‐Meei Huang, Hsio‐Chung Ou, HUAN‐LIAN CHEN, Rolis Chien‐Wei Hou, Kee Ching G. Jeng · 2005 · Annals of the New York Academy of Sciences
  72. A new etiologic model for Alzheimers Disease
    Kathryn A. Schiel · 2017 · Medical Hypotheses
  73. Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice
    Busenur Ceyhan, Parisa Nategh, Mehrnoosh Neghabi, Jacob LaMar, Shalaka Konjalwar, Peter Rodriguez, Maureen K. Hahn, Matthew Gross, Gregory J. Grumbar, Kenneth J. Salleng et al. · 2024 · IEEE Journal of Translational Engineering in Health and Medicine
  74. The effect of aluminum on mitochondrial dysfunctions
    Mariana Machado‐Neves, Fernanda Carolina Ribeiro Dias, Graziela Domingues de Almeida Lima, Iara Magalhães Ribeiro · 2022 · Elsevier eBooks
  75. Diet, Cerebral Energy Metabolism, and Psychological Functioning
    David Benton · 2005 · Nutrition, brain, and behavior./Nutrition, brain and behavior
  76. Alpha7 Nicotinic Acetylcholine Receptor Down Regulation Impairs Mitochondrial Function in Streptozotocin-induced Sporadic Alzheimer's Disease Model in Rats
    Niraj Kumar Singh, Debapriya Garabadu · 2021 · Indian Journal of Pharmaceutical Education and Research
  77. Targeting Calpain-2 for Alzheimer’s Disease Treatment
    Amy F.T. Arnsten, Michel Baudry · 2023 · Medical Research Archives
  78. Alteration of calcium signaling as one of the mechanisms of Alzheimer's disease and diabetic polyneuropathy
    O P Kostiuk, T. Yu. Korol’, Sergiy V. Korol, SV Romanenko, V. Pinchenko, P G Kostiuk · 2010 · Fìzìologìčnij žurnal
  79. Brain metabolic and functional alterations in a liver-specific PTEN knockout mouse model
    Ishan Patil, H. Sancheti, Bangyan L. Stiles, E. Cadenas · 2018 · PLoS ONE
  80. Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?
    Irene Ablinger, Katharina Dressel, Thea Rott, Anna Andrea Lauer, Michael Tiemann, João Pedro Batista, Tim Taddey, Heike S. Grimm, Marcus O.W. Grimm · 2022 · Biomedicines
  81. Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects
    R. Swerdlow, M. D. de Leon, D. Marcus · 2021 · Journal of Alzheimer's disease reports
  82. Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity—In Vitro Study
    Jana Hroudová, Tereza Nováková, Jan Korábečný, David Maliňák, Lukáš Górecki, Zdeněk Fišar · 2020 · Molecular Neurobiology
  83. Neurodegenerative diseases
    Anil Gupta · 2021 · Elsevier eBooks
  84. Chaperone-Like Manner of Human Neuronal Tau Towards Lactate Dehydrogenase
    Rui Tian, Chunlai Nie, Rongqiao He · 2004 · Neurochemical Research
  85. An overview on pathophysiology and therapeutic approaches of Alzheimer's disease and Parkinson's disease
    Krishnendu Adhikary, Riya Sarkar, Sumana Roy Chowdhury, Pradipta Banerjee · 2024 · Elsevier eBooks
  86. Aberrant mitochondrial RNA in the role of aging and aging associated diseases
    Yucai Chen, William Davis Parker, Hong‐Yi Chen, Kunfang Yang · 2015 · Medical Hypotheses
  87. Mitochondrial Dysfunction and Molecular Bases of Neurodegenerative Diseases
    Evgenia E. Kolesnikova · 2013 · Neurophysiology
  88. Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer’s disease
    Morgan Newman, Lena Halter, Anne Lim, Michael T. Lardelli · 2017 · PLoS ONE
  89. Is antioxidant therapy effective to treat alzheimer's disease?
    Ana Lloret, Esther Giraldo, José Viña · 2011 · Free Radicals and Antioxidants
  90. Amyloid-β and Mitochondrial Membranes: A Missing Link in Alzheimer’s Pathogenesis
    Aneta Houfkova, Monika Schmidt · 2026 · Molecular Neurobiology
  91. Lipid Peroxidation and Age-Related Neurodegenerative Disorders
    C. Spickett, H. Forman · 2015 · CRC Press eBooks
  92. Identification of a novel truncated pathogenic variant in PUS1 gene in two siblings of consanguineous Tunisian family: intrafamilial phenotypic variability related to mtDNA copy number
    Marwa Ammar, Sana Kmiha, Marwa Maalej, Rahma Felhi, Marwa Kharrat, Olfa Alila‐Fersi, Jihen Chouchen, Ines Maaloul, Emna Mkaouar‐Rebai, Thouraya Kamoun et al. · 2025 · Annals of Hematology
  93. Alzheimer’s Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)
    Agueda A. Rostagno, Jorge A. Ghiso · 2025 · Antioxidants
  94. 13C NMR Spectroscopy as a Tool in Neurobiology
    Asta Kristine Haberg, Ursula Sonnewald, Janniche Hammer, Torun Margareta Melø, Haytham Eloqayli · 2011 · Advances in neurobiology
  95. Oxidative Stress, Cognitive Dysfunction, and Brain Aging
    Elizabeth Head, Steven C. Zicker · 2011 · Oxidative stress in applied basic research and clinical practice
  96. Amyloid Toxicity, Synaptic Dysfunction, and the Biochemistry of Neurodegeneration in Alzheimer’s Disease
    Judy Ng, Marie‐Isabel Aguilar, David Henry Small · 2006 · Springer eBooks
  97. Proteomics analysis of mitochondrial dysfunction triggered by complex specific electron transport chain inhibitors reveals common pathways involving protein misfolding in an SH-SY5Y in vitro cell model
    Betül Şahin, Ahmet Tarık Baykal · 2017 · TURKISH JOURNAL OF BIOLOGY
  98. Cellular and Molecular Mechanisms Underlying Synaptic Degeneration and Neuronal Death in Alzheimer's Disease
    Mark P. Mattson, Ward A. Pedersen, Carsten Culmsee · 2001 · Humana Press eBooks
  99. Antioxidants Combined with Behavioral Enrichment Can Slow Brain Aging
    Elizabeth Head · 2010 · Humana Press eBooks
  100. Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions
    Abhishek Kumar, Mohit Kumar, Aniket Verma, Ritu Joshi, Megha Bidlan, Ravneet Singh · 2025 · Current Behavioral Neuroscience Reports